Investor Relations

Recent News
Feb 12, 2021

Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer, today announced that President and Chief Executive...

Feb 9, 2021

Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer, granted a stock option to a new employee as approved...

Jan 5, 2021

Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer, today announced that President and Chief Executive...

View all news releases

Events and Webcasts
Investor Enquiries

Dede Sheel
Vice President, Investor Relations
investors@sierraoncology.com

Sign up for investor alerts